Epstein–Barr virus-associated lymphomas C Shannon-Lowe, AB Rickinson, AI Bell Philosophical Transactions of the Royal Society B: Biological Sciences 372 …, 2017 | 390 | 2017 |
The global landscape of EBV-associated tumors C Shannon-Lowe, A Rickinson Frontiers in oncology 9, 713, 2019 | 366 | 2019 |
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells CD Shannon-Lowe, B Neuhierl, G Baldwin, AB Rickinson, HJ Delecluse Proceedings of the National Academy of Sciences 103 (18), 7065-7070, 2006 | 290 | 2006 |
The Epstein–Barr virus and the pathogenesis of lymphoma M Vockerodt, LF Yap, C Shannon‐Lowe, H Curley, W Wei, K Vrzalikova, ... The Journal of pathology 235 (2), 312-322, 2015 | 276 | 2015 |
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation J Zuo, A Currin, BD Griffin, C Shannon-Lowe, WA Thomas, ME Ressing, ... PLoS pathogens 5 (1), e1000255, 2009 | 202 | 2009 |
Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification C Shannon-Lowe, E Adland, AI Bell, HJ Delecluse, AB Rickinson, ... Journal of virology 83 (15), 7749-7760, 2009 | 155 | 2009 |
Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection C Shannon-Lowe, M Rowe PLoS pathogens 7 (5), e1001338, 2011 | 154 | 2011 |
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers L Fultang, S Panetti, M Ng, P Collins, S Graef, N Rizkalla, S Booth, ... EBioMedicine 47, 235-246, 2019 | 137 | 2019 |
SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely ill patients M Olbei, I Hautefort, D Modos, A Treveil, M Poletti, L Gul, ... Frontiers in immunology 12, 629193, 2021 | 114 | 2021 |
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs CD Wood, H Veenstra, S Khasnis, A Gunnell, HM Webb, ... Elife 5, e18270, 2016 | 106 | 2016 |
Epstein Barr virus entry; kissing and conjugation C Shannon-Lowe, M Rowe Current opinion in virology 4, 78-84, 2014 | 105 | 2014 |
Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle NP Croft, C Shannon-Lowe, AI Bell, D Horst, E Kremmer, ME Ressing, ... PLoS Pathogens 5 (6), e1000490, 2009 | 105 | 2009 |
Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition HM Long, AM Leese, OL Chagoury, SR Connerty, J Quarcoopome, ... The Journal of Immunology 187 (1), 92-101, 2011 | 102 | 2011 |
Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells Z Stamataki, C Shannon-Lowe, J Shaw, D Mutimer, AB Rickinson, ... Blood, The Journal of the American Society of Hematology 113 (3), 585-593, 2009 | 99 | 2009 |
Epstein–Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth C Shannon-Lowe, G Baldwin, R Feederle, A Bell, A Rickinson, ... Journal of General Virology 86 (11), 3009-3019, 2005 | 89 | 2005 |
Unexpected patterns of Epstein–Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA RJ Tierney, CD Shannon-Lowe, L Fitzsimmons, AI Bell, M Rowe Virology 474, 117-130, 2015 | 88 | 2015 |
Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology E Heath, N Begue-Pastor, S Chaganti, D Croom-Carter, C Shannon-Lowe, ... PLoS pathogens 8 (5), e1002697, 2012 | 84 | 2012 |
A novel latent membrane 2 transcript expressed in Epstein-Barr virus–positive NK-and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy CP Fox, TA Haigh, GS Taylor, HM Long, SP Lee, C Shannon-Lowe, ... Blood, The Journal of the American Society of Hematology 116 (19), 3695-3704, 2010 | 84 | 2010 |
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells CP Fox, C Shannon-Lowe, P Gothard, B Kishore, J Neilson, N O'Connor, ... Clinical infectious diseases 51 (1), 66-69, 2010 | 81 | 2010 |
Epstein‐Barr virus B95. 8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to … R Feederle, B Neuhierl, H Bannert, K Geletneky, C Shannon‐Lowe, ... International journal of cancer 121 (3), 588-594, 2007 | 76 | 2007 |